Equity Research, Broker Reports, and media content on DMD DIGITAL HEALTH CONNECTI0

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about DMD DIGITAL HEALTH CONNECTI0
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard
Login

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on DMD DIGITAL HEALTH CONNECTI0. We currently have 0 research reports from 0 professional analysts.

Open
N/A
Range Today
N/A
52 Week
0.00/0.00
Daily Volume
N/A
# Shares
0m
Daily Liquidity
0.0%
Pension Liability
Enterprise Value
n/am
Market Cap
0m
Latest PE (hist)
Div Yield

Latest News/RNS

(more news)
Date Source Announcement
Get free RNS email alerts

  • Frequency of research reports

     

  • Research reports on

    DMD DIGITAL HEALTH CONNECTI0

  • Providers covering

    DMD DIGITAL HEALTH CONNECTI0

  • 23 Jul 19

Quarterly Research Outlook - Summer 2019

In January, we provided a list of 11 stocks for 2019 that we believed would perform strongly with attractive catalysts that could lead to material outperformance. In this Quarterly Research Outlook, we revisit these views, analysing what has happened and how the remaining six months of the year could play out.

Companies: AMS ANX ARS ATYM AVON BLVN PIER BUR CGS CAML CALL CSRT TIDE CYAN DTG DEMG ELM EMR FPO FST GTLY GENL GRI GEEC GKP HMI HAYD HEAD HILS HTG HUR HYR IBPO IOG INDI JHD JOG KAPE KEYS KCT KGH LAM LIT LOK MACF MANO PCA PANR PXC PHC PMO RBW RMM REDD RSW RNO RKH RBGP ROR SUS SCPA SHG SOLG SOM TWD TRAK TSG TRI VNET VTC ZOO ZTF

  • 02 Jul 19

Where’s the Value?

Warren Buffett once said that as an investor, it is wise to be ‘fearful when others are greedy and greedy when others are fearful’. Fear is not in short supply right now.

Companies: OPM ALU ANCR BLV CONN CRC FDL GATC HAT LEK MMH MCB MWE NXR NTBR NOG PAF PEG RFX SRC TEF TEG TPT VTU WYN XLM

  • 12 Sep 19

Adding Property Developers

OnTheMarket, the agent-backed company which operates the OnTheMarket.com property portal, is pleased to announce that it has signed a portal listing and additional advertising products agreement with Barratt Developments PLC, Britain's largest housebuilder.

Companies: OnTheMarket
  • 27 Aug 19

Foreign buyers gorging on UK stocks

Like whales feasting on Krill, overseas firms are today stuffing themselves silly with choice fillets of corporate Britain. Why? Well look no further than geopolitical tensions and Brexit, which have disproportionately impacted UK equities and the £. Indeed the FTSE100 has lagged the S&P500 by a hefty 19% over the past 2 years, with Sterling dropping to 34 year lows vs US$ (see below). That said to us, based purely on fundamentals, this period of underperformance appears over-cooked, leaving many quality British companies vulnerable to predatory interest.

Companies: VOD AV/ AGK CHG CNA ITV BRBY SMIN CTEC SXS OXIG MGAM IMI WEIR WMH KMK EYE GATC ULS INS ALFA RDT TSTL ELCO MBH BLTG IHC 9537 CSRT NBI

  • 09 Sep 19

Allenby Capital TMT Update 09.09.19 (BIRD.L, MIRA.L, BOOM.L)

Blackbird plc* (BIRD.L, 11p/£32.5m) | Mirada plc* (MIRA.L, 1.4p/£12.5m) | Audioboom plc* (BOOM.L, 210p/£29.4m)

Companies: BIRD MIRA BOOM

  • 07 Jun 19

The Mission Marketing Group - Capital markets day (CMD): Breadth of value

The recent CMD allowed themission’s newly-appointed CEO, James Clifton, to outline the direction of travel to best leverage group strengths. It also showcased Krow, bought in April 2018, and businesses being developed within the Fuse incubator, particularly Pathfindr. There was no new financial information. Increasing collaboration across group agencies gives a solid base for more cross- and up-selling to the low-churn, blue-chip client base. The valuation remains at a sizable discount to peers.

Companies: The Mission Marketing Group
  • 21 Aug 19

Supporting clients through FDA approval

Cello has acquired Innovative Science Solutions LLP (ISS) for an initial $6.4m in cash (maximum $10.5m). ISS is a scientific consulting firm specialising in strategic counsel and regulatory support for the healthcare industry in the US. It adds a new and key component to Cello’s offering of technical services along critical drug development pathways. The addition of ISS is in line with the group’s strategy of growing its technical services offering in the US healthcare market and we have upgraded our FY 2019E EPS by 2% and FY 2020E by 7%, after allowing for investment in headcount to support growth. We continue to expect the group to have net cash at December 2019E, meaning further enhancing additions could be financed from existing resources if opportunities can be found. We have raised our target price to 160p from 145p, valuing Cello at a 30% discount to peers on a P/E basis.

Companies: Cello Health
  • 27 Aug 19

VMware spends $5bn on cloud security, Salesforce provides strong outlook, Amazon acquires Indian supermarket chain

VMware said on Thursday it bought two providers of cloud security and cloud developer services in separate deals valued at about $5 billion, as it expands offerings for corporate clients. VMware bought Pivotal Software Inc in a $2.7 billion deal. Separately, VMware said it would buy software maker Carbon Black Inc for about $2 billion in cash.

Companies: CALL KAPE AVST CNS DFX ECK ECSC FLX IGP LOOP NCC NET OSI SOPH

  • 29 Aug 19

Positive drilling at West Newton

The update on the West Newton is notable in detailing a potentially material oil discovery, as well as the long-mooted gas discovery. In particular, the operator (Rathlin Energy) has now confirmed that the West Newton project contains an estimated gross 151 feet oil column located below a gross 66 feet gas column within the Kirkham Abbey formation. Deloitte will now be commissioned to prepare a CPR to assess volumetrics at West Newton and to undertake an economic evaluation applicable to a material oil development with an associated gas cap. This exciting news will inevitably result in changes to the development programme for the asset.

Companies: Reabold Resources
  • 05 Sep 19

LIBERUM: 4imprint Group* - Strong returns on marketing continue

Interim results were ahead of our estimate, with 16% organic revenue growth. Revenue per marketing dollar remained constant yoy at $5.12 despite an $11m increase in marketing costs to $79.2m.

Companies: 4Imprint Group
  • 30 Jun 16

AIMing for income

So what is the profile of a typical AIM quoted company? The market’s detractors may argue that London’s junior market is peppered with cash consuming companies that are not sufficiently advanced in their route to profitability nor corporate governance regimes to justify their listing. Supporters of the London Stock Exchange’s growth market would say that the Alternative Investment Market is the world’s most successful market for growing companies rewarding investors prepared to brave the risks of earlier stage funding, and driving innovation and job creation. Neither view suggests that AIM would be a fertile hunting ground for income generating stocks. However a glance at the FTSE AIM All Share constituents (Source: Fidessa) suggests that over 250 of its members or circa a quarter of the market’s members pay dividends.

Companies: BVXP BOTB ITQ SHOE CGS DX/ HSP JIL IBEX PRP CAML GTC JIM CCAP ENTU FXI NAH ASY HGM PEN PEG AVG NXR

  • 21 Jun 16

The return of the goodwill IPO: How to value a brand?

I wake up in my DFS (DFS) bed with a Gin and Fevertree (FEVR) hangover, place a trade on my phone through CMC Markets (CMCX), have a quick go on my Hornby (HRN) train set, eat half a box of Hotel Chocolat (HOTC), all before heading out in my brand spanking new Joules (JOUL) wellies to my local Metro Bank (MTRO) branch. All of these well-known consumer brands share a common theme in that they are all listed or quoted on the London Stock Exchange. It’s been a year so far reminiscent of 2014 when we saw a flurry of large brands rush for the IPO door such as Pets at Home (PETS), Saga (SAGA), AA (AA) and Poundland (PLND). Most looking for a private equity exit. The IPO adventure of these companies tends to be fairly boiler plate: the valuation is a battleground between the exiting private equity house and incoming institutional investors, the book is many times covered and the scale backs are eye watering. But what makes these companies more alluring to investors than a company nobody has ever heard of which in fact may be profitable, dividend paying and ultimately, on a lower valuation?

Companies: CMCX CSP CYBG WJG ACRL ASCL

  • 09 Apr 19

The Mission Marketing Group - Another year of progress

Themission’s FY18 results were in line with the trading update, with good top-line growth (buoyed by the Krow acquisition), higher operating margins and a balance sheet strengthened by the £3.0m profit on the sale of BroadCare in November. Cash flow should comfortably cover future earn-out commitments. The appointment of James Clifton (of in-house agency bigdog) as group CEO should help to drive further collaboration across the 28 offices, with more cross- and up-selling to the low-churn, blue-chip client base. The valuation remains at a sizable discount to peers.

Companies: The Mission Marketing Group
  • 12 Apr 19

Ebiquity - A guiding hand for advertisers

With the disposal of Ad Intel completed, Ebiquity is now focused on building its business as an independent adviser to global advertisers on measuring and optimising their media spend. The recently strengthened management team aims to improve margins from FY18 levels, but the need to adjust overheads to suit the size of the continuing operations will weigh on current year profitability. The unbundling should, however, set up the group for stronger progress thereafter. The balance sheet is significantly stronger, yet the rating is not recognising the improved investment case.

Companies: Ebiquity
  • 11 Jun 19

YouGov - Data: the connecting currency

YouGov continues to develop its data, platform and tools to address significant opportunities to embed in clients’ workflows, particularly within the marketing segment. Its new five-year growth plan to FY23 targets building out its panel, data and client base globally, doubling group revenue and operating margin and achieving a CAGR of over 30% for EPS. Given the investment required to achieve this, we expect progress towards these targets to be weighted to the latter part of the period. Strong share price performance puts the rating (on unchanged estimates) at the top of the global peer range and reflects the scale of management’s ambitions.

Companies: YouGov